Search the Newsreel

Why Resverlogix Corp. stock is skyrocketing today

VerifyMe Q2 EPS $(0.04) misses $(0.02) estimate; sales miss

Ameriprise, Columbia report 6.3% Diversified Energy (DEC) ownership stake

Die Verizon-Communications-Aktie legt nach soliden Quartalszahlen zu

Ameriprise Financial (FVRR) reports 9.8% Fiverr stake via Columbia unit

Ameriprise Financial, Inc. and its subsidiary Columbia Management Investment Advisers, LLC have reported a significant beneficial ownership in Fiverr International Ltd (FVRR) common stock. Ameriprise holds 3,525,023 shares, representing 9.8% of the class, while Columbia Management Investment Advisers holds 3,229,295 shares, or 9.0%. Both …

T. Rowe Price Associates (VRRM) reports 241,697 Verra Mobility shares in 13G/A

T. Rowe Price Associates, Inc. has filed an amended Schedule 13G/A, reporting beneficial ownership of 241,697 shares of Verra Mobility Corp. common stock. This holding represents 0.2% of Verra Mobility's outstanding common stock. T. Rowe Price Associates maintains sole voting and dispositive power over …

Verastem, Inc. (VSTM) sees 7.76% ownership reported by Armistice Capital

Armistice Capital, LLC and Steven Boyd have reported a significant beneficial ownership stake of 7.76% in Verastem, Inc. (VSTM), totaling 7,024,000 shares. This ownership is held with shared voting and dispositive power through Armistice Capital Master Fund Ltd., where Armistice Capital acts as the …

ES|Eversource Energy|Price:72.200|Chg%:-0.020

Why GE Vernova (GEV) Is Emerging as an AI Power Winner

Polen Capital Management Llc released its "Polen Focus Growth Strategy" Q2 2026 investor letter. A copy of the letter can be downloaded here. Polen Focus Growth returned 6.33% (net of fees) in the second quarter of 2026, significantly underperforming the Russell 1000 Growth Index's …

PAAS Q2 Earnings Call Keeps Silver View, Flags Gold Pressure

HC Wainwright Has Positive Estimate for VERA Q3 Earnings

Why Discovery Silver Corp. stock went up yesterday

UBS Adjusts Wolverine World Wide PT to $31 From $29, Maintains Buy Rating

UBS has increased its price target for Wolverine World Wide (WWW) shares to $31 from $29, while reiterating a Buy rating on the stock. This adjustment follows Wolverine World Wide's Q2 2026 earnings call, where the company reported rising adjusted earnings and revenue, and …

Universal Electronics (UEIC): Ameriprise group reports 8.1% stake in 13G/A

Ameriprise Financial, Inc., through its subsidiaries Columbia Management Investment Advisers, LLC, and Columbia Small Cap Value Discovery Fund, has reported an 8.1% beneficial ownership stake in Universal Electronics Inc. (UEIC) as of June 30, 2026. The group collectively owns 1,026,032 shares, with the Columbia …

Are Construction Stocks Lagging Century Communities (CCS) This Year?

The Construction group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Century Communities (CCS) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. …

Vertex Pharmaceuticals: I Was Wrong About Its Near-Term Prospects (Rating Upgrade)

Warner Bros’ ‘The End of Oak Street’ targets up to $48M global debut

Pan American Silver Corp. (TSX:PAAS) Shares Slide 9.78% as Earnings Pressure, Gold Output Concerns and Market Caution Weigh on Investor Sentiment

Diversified Royalty Corp. (TSX:DIV) Shares Slide Into Negative Territory as Growth Concerns, Payout Pressure and Investor Caution Rise

Clover Health Is Proving Its Profit Model (NASDAQ:CLOV)

Warner Bros. Discovery (WBD) Faces A 53% Fair Value Gap As Earnings Land

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Warner Bros. Discovery (WBD) is back in focus after reporting second quarter 2026 earnings, with revenue of US$8.7b and net income of US$149 …

Crinetics Pharmaceuticals merger with Vertex Pharmaceuticals advances after regulatory clearances

The proposed merger between Crinetics Pharmaceuticals (NASDAQ:CRNX) and Vertex Pharmaceuticals (NASDAQ:VRTX) has progressed after securing regulatory clearances, including the expiration of the Hart-Scott-Rodino Antitrust Improvements Act waiting period and approvals in Austria, Germany, and Australia. The acquisition, valued at approximately $10 billion, is expected …

Resverlogix Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Everest Medicines Reshapes Board With Director Resignation and New Appointment

River Global Capital Reduction Takes Effect as Tax Burden Eases for D Shareholders

Is the Options Market Predicting a Spike in Avery Dennison Stock?

Investors in Avery Dennison Corporation AVY need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 18, 2026 $140 Call had some of the highest implied volatility of all equity options today. What …

Wolverine World Wide posts strong growth in Merrell and Saucony, maintains Hold rating amid market risks

Wolverine World Wide reported strong operational growth in its Merrell and Saucony brands, leading to margin expansion. Despite the positive results, the stock maintains a Hold rating due to cyclical risks in wholesale inventory and consumer spending. The analyst suggests waiting for clearer market …

Vertex to acquire Crinetics after HSR clearance; closing expected early Sept

Crinetics Pharmaceuticals announced that it has received HSR clearance for its merger with Vertex. The HSR waiting period expired on August 12, 2026, and antitrust approvals have also been secured in Austria, Germany, and Australia. The merger's closing is targeted for early September 2026, …

These Analysts Raise Their Forecasts On Wolverine World Wide Following Strong Q2 Results

Robert W. Baird Forecasts Strong Price Appreciation for Wolverine World Wide (NYSE:WWW) Stock

Q3 EPS Estimate for Kyverna Therapeutics Lifted by Analyst

HC Wainwright has increased its Q3 2026 EPS estimate for Kyverna Therapeutics (NASDAQ:KYTX) to a loss of $0.66 per share, an improvement from its previous forecast of a $0.78 loss. The firm maintained a "Buy" rating and a $25.00 price target for the stock. …

Punch & Associates (IIIV) reports 5.6% beneficial stake in i3 Verticals

Punch & Associates Investment Management, Inc. has reported a beneficial ownership of 1,099,486 shares of i3 Verticals, Inc. common stock, which accounts for 5.6% of the class. The firm holds sole voting and dispositive power over these shares, indicating complete control over the position. …

Crinetics Pharmaceuticals (CRNX) advances Vertex merger after key antitrust milestones

Crinetics Pharmaceuticals announced significant progress in its planned acquisition by Vertex Pharmaceuticals, with the Hart-Scott-Rodino waiting period expiring and antitrust approvals secured in Austria, Germany, and Australia. The merger's completion hinges on Crinetics shareholder approval at a meeting on August 28, 2026, with an …

Professional Diversity Network Reports $1.18 Million Second-Quarter Revenue

Professional Diversity Network (IPDN) details Q2 2026 results in new press release

Professional Diversity Network (NASDAQ: IPDN) warns on going concern amid wider 2026 loss